Guardant Health and Susan G. Komen® Partner to Develop Clinical Studies to Identify Early-Stage Breast Cancer Patients Who May Benefit From Additional Monitoring or Therapy
December 21, 2022San Francisco Biotechnology Network NewsNewsComments Off on Guardant Health and Susan G. Komen® Partner to Develop Clinical Studies to Identify Early-Stage Breast Cancer Patients Who May Benefit From Additional Monitoring or Therapy
PALO ALTO, Calif. & DALLAS--(BUSINESS WIRE)--Guardant Health & Susan G. Komen partner to develop studies to identify breast cancer patients who may benefit from additional monitoring or therapy.